Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Epidemiology|October 15, 2018
Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patientsKoen Degeling, Mira D Franken, Anne M May, et al.
Health and Quality of Life Outcomes|July 22, 2020
Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness modelMira D Franken, Anne de Hond, Koen Degeling, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2025
Model-informed development of a cost-saving dosing regimen for enfortumab vedotinCatharina Jp Op 't Hoog, Amy Rieborn, Dirk Jan Ar Moes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2024
Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trialS van Wilpe, I S H Kloots, P H J Slootbeek, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2017
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancerM D Franken, E M van Rooijen, A M May, et al.
JCI Insight|January 30, 2025
Multimodal integration of blood RNA and ctDNA reflects response to immunotherapy in metastatic urothelial cancerSandra van Wilpe, Davide Croci, Sara S Fonseca Costa, et al.
Pageof 3